Earkart (EARKART) Share Price Falls 9.38% to Rs 125.05: What Today’s Decline Shows

Earkart Share Price fell to Rs 125.05 today, down 9.38%, taking the company’s market capitalisation to Rs 189.8 crore. The Micro Cap stock opened at Rs 125.05 and remained at that level through the session snapshot, against a previous close of Rs 138. For investors tracking Earkart Share Price Today, the supplied data confirms a sharp same-day decline, but it does not establish a company-specific catalyst behind the move.

That is why the stock is attracting attention in today’s Stock Market Today and Share Market Today discussion. The price action itself is notable, while the broader numbers add context: RSI stands at 32.93, the stock is below its 50-day moving average of Rs 132.16, the P/E ratio is 38.48, P/B is 2.95, ROE is 40.63%, ROCE is 44.39%, EPS is 3.59 and book value per share is Rs 46.85. Investors watching Earkart Stock News and Earkart Share News should next monitor whether the stock stabilises around current levels and how its valuation and profitability compare with its Healthcare industry peers, according to Univest analysis.

Earkart (EARKART) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 125.05
Previous Close	Rs 138
Today's Move	-Rs 12.95 (-9.38%)
Open	Rs 125.05
High	Rs 125.05
Low	Rs 125.05
Turnover	Rs 0.01 crore
Market Capitalisation	Rs 189.8 crore
Market Cap Category	Micro Cap

Earkart Share Price Today reflects a one-session reset from the previous close of Rs 138 to Rs 125.05, a decline of Rs 12.95 or 9.38%. The day’s open, high and low were all Rs 125.05 in the supplied market snapshot, showing that the quoted price held at that level through the captured period. Turnover stood at Rs 0.01 crore, which underlines that the day’s move is being discussed primarily because of the size of the percentage decline rather than a broader set of verified catalysts.

For traders and investors following Earkart Share Price Live and Earkart Share Price Update, this means the stock moved quickly to a lower reference point early in the session. As a Micro Cap company with a market cap of Rs 189.8 crore, even a single-day move of this size can bring it into Market News and Stocks in News conversations. The available data confirms the decline, but not the reason. From here, the immediate question is whether the weakness is also visible in the stock’s underlying technical position and broader valuation context, which is where Univest turns next.

Earkart (EARKART) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 189.8 crore
P/E Ratio	38.48x
P/B Ratio	2.95x
ROE	40.63%
ROCE	44.39%
EPS	Rs 3.59
Book Value Per Share	Rs 46.85
Dividend Yield	0%

Earkart Fundamental Analysis shows a mix of strong profitability ratios and a valuation that still sits above the industry median on earnings. At Rs 189.8 crore in market capitalisation, Earkart remains a Micro Cap stock, which defines size rather than quality. The company is trading at a P/E ratio of 38.48 and a P/B ratio of 2.95. Its EPS is 3.59, which represents earnings attributable to each share, while book value per share is Rs 46.85, indicating the accounting net worth behind each share. Dividend yield is 0, so the current data does not show a historical cash payout support for the stock price.

Profitability metrics are notable. ROE stands at 40.63% and ROCE at 44.39%, both of which are high in absolute terms and well above several peer figures supplied in the same industry set. That makes today’s Earkart Share Price Fall more interesting from a stock analysis perspective: the market is marking down a business that, on the supplied numbers, shows strong returns on equity and capital. At the same time, a 38.48 P/E means the stock is not obviously cheap on earnings relative to every peer. Univest therefore sees today’s Earkart Stock News as a case where price weakness, profitability strength and valuation discipline need to be read together rather than in isolation.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Medical Equipment/Supplies/Accessories
Benchmark Scope	same industry
Company P/E Ratio	38.48x
Benchmark Median P/E	31.82x
Benchmark Average P/E	88.87x
Benchmark P/E Range	7.35x to 1,004.34x
Company P/B Ratio	2.95x
Benchmark Median P/B	3.37x
Benchmark Average P/B	4.08x
Company ROE	40.63%
Benchmark Median ROE	15.01%
Benchmark Average ROE	16.49%
Company ROCE	44.39%
Benchmark Median ROCE	16.41%
Benchmark Average ROCE	17.83%
Company Market Capitalisation	Rs 189.8 crore
Benchmark Median Market Cap	Rs 187.15 crore
Benchmark Average Market Cap	Rs 6,611.5 crore

Earkart operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry, and the benchmark data gives useful context for today’s decline. Within the same industry, the benchmark scope covers 22 companies. Earkart’s P/E of 38.48 is above the industry median P/E of 31.82 but below the industry average of 88.87, with the full P/E range stretching from 7.35 to 1,004.34 across 21 companies. That places the stock above the midpoint of typical earnings valuation, but far from the most expensive end of the group.

On price-to-book, Earkart’s 2.95 is below the industry median of 3.37 and below the average of 4.08, within a range of 0.42 to 13.49 across 21 companies. Profitability stands out more strongly. Earkart’s ROE of 40.63% is far above the industry median of 15.01% and average of 16.49 among 22 companies. Its ROCE of 44.39% is also comfortably ahead of the industry median of 16.41% and average of 17.83. In market-cap terms, Earkart at Rs 189.8 crore is close to the industry median of Rs 187.15 crore, though well below the average of Rs 6,611.5 crore because the upper end reaches Rs 1,20,716.54 crore while the minimum is Rs 3.33 crore. For readers following Earkart Market Cap and Earkart Company News, that suggests a business with peer-group-sized market value but stronger-than-benchmark return ratios.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
LENSKART SOLUTIONS	LENSKART	1,20,716.54	183.97	13.49	6.85	12.55
Poly Medicure	POLYMED	17,472.69	56.22	5.57	10.94	14.05
Q-LINE BIOTECH	QLINE	1,576.29	29.29	0	26.05	23
3B Blackbio Dx	3BBLACKBIO	1,263.45	22.36	4.43	19.41	26.03
LAXMI DENTAL	LAXMIDENTL	1,102.79	36.1	4.41	21.4	24.97

Earkart’s peer comparison shows why the stock remains worth tracking despite today’s decline. Against LENSKART SOLUTIONS, Earkart trades at a much lower P/E of 38.48 versus 183.97 and a much lower P/B of 2.95 versus 13.49, while also posting a far higher ROE of 40.63% against 6.85% and ROCE of 44.39% against 12.55%. Compared with Poly Medicure, Earkart again has a lower P/E than 56.22 and lower P/B than 5.57, while its ROE and ROCE are well above 10.94% and 14.05%.

Versus Q-LINE BIOTECH, 3B Blackbio Dx and LAXMI DENTAL, Earkart trades at a higher P/E than 29.29, 22.36 and 36.1 respectively, but it also reports stronger profitability than those peers on the supplied return metrics. Q-LINE’s ROE and ROCE are 26.05% and 23%, 3B Blackbio’s are 19.41% and 26.03%, and LAXMI DENTAL’s are 21.4% and 24.97%. The clear weakness is scale: Earkart’s market cap of Rs 189.8 crore is much smaller than these listed peers, whose market values range from Rs 1,102.79 crore to Rs 1,20,716.54 crore in this comparison set. That mix of smaller size, decent valuation balance and superior return ratios helps explain why Univest is watching Earkart Share Price and Earkart Stock Performance closely.

Why Investors Are Watching Earkart

• The stock declined 9.38% in a single session, falling Rs 12.95 from Rs 138 to Rs 125.05.
• RSI at 32.93 and price below the 50 DMA of Rs 132.16 show weak short-term momentum context.
• P/E at 38.48 is above the industry median of 31.82, but P/B at 2.95 is below the median of 3.37.
• ROE of 40.63% and ROCE of 44.39% are both well above industry median and average levels.
• The company’s Rs 189.8 crore market cap is close to the industry median of Rs 187.15 crore, despite a much smaller scale than larger peers.

About Earkart

Earkart is classified within the Healthcare sector and specifically in the Medical Equipment/Supplies/Accessories industry. Based on the verified company context available for this article, that places the business in a segment linked to medical products and healthcare-related equipment supply chains. In market-value terms, Earkart is a Micro Cap company at Rs 189.8 crore, which puts it near the median size of its direct industry benchmark even though it remains far smaller than larger listed names such as Lenskart Solutions and Poly Medicure. For readers tracking Earkart Latest News and Earkart Stock Analysis on Univest, that industry positioning is central to understanding how the stock is valued.

Track Earkart Share Price on Univest

UseEarkart (EARKART) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.

On Univest, investors can track Earkart Share Price, Earkart Share Price Today, fundamental ratios such as P/E, P/B, ROE, ROCE, EPS and book value, along with 52-week levels, market-cap data and broader market insights. Univest also helps users compare Earkart Stock News with sector benchmarks and peer metrics, making it easier to place a sharp one-day move like today’s decline in a wider analytical context.

Frequently Asked Questions

Why is Earkart Share Price falling today?

Ans. Earkart Share Price fell because the stock moved down to Rs 125.05 from the previous close of Rs 138, a decline of 9.38%. The supplied data confirms the move, but it does not establish a company-specific catalyst.

What is Earkart Share Price Today?

Ans. Earkart Share Price Today is Rs 125.05. The stock is down Rs 12.95 or 9.38% versus its previous close of Rs 138, and the company’s market capitalisation in the supplied data stands at Rs 189.8 crore.

Is Earkart a micro cap stock?

Ans. Yes, Earkart is classified as a Micro Cap stock in the supplied data. Its market capitalisation is Rs 189.8 crore, which is close to the industry median market value of Rs 187.15 crore.

What does today’s price action show for Earkart?

Ans. The stock opened at Rs 125.05 and the supplied snapshot shows the day’s open, high and low were all Rs 125.05. Against the previous close of Rs 138, that reflects a sharp reset to a lower trading level.

What valuation ratios does Earkart currently trade at?

Ans. Earkart trades at a P/E ratio of 38.48 and a P/B ratio of 2.95 in the supplied data. That places its earnings valuation above the industry median P/E of 31.82 but its book valuation below the median P/B of 3.37.

How profitable is Earkart compared with its industry?

Ans. Earkart reports ROE of 40.63% and ROCE of 44.39%, which are both well above the same-industry medians of 15.01% and 16.41%. On the supplied numbers, profitability is stronger than the benchmark average too.

What do EPS, book value and dividend yield show for Earkart?

Ans. Earkart’s EPS is 3.59, showing earnings attributable to each share, while book value per share is Rs 46.85. Dividend yield is 0, which means the supplied data does not show a current historical payout support.

How does Earkart compare with listed peers?

Ans. Earkart’s P/E of 38.48 is lower than Lenskart’s 183.97 and Poly Medicure’s 56.22, but higher than Q-LINE’s 29.29, 3B Blackbio’s 22.36 and LAXMI DENTAL’s 36.1. Its ROE and ROCE exceed all five supplied peers.

What should investors monitor next in Earkart Stock News?

Ans. Investors can monitor whether Earkart Share Price holds around Rs 125.05, whether it remains below the 50 DMA of Rs 132.16, and how its valuation and profitability continue to compare with direct Healthcare industry peers.